Related Experiment Video
Updated: Jun 18, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis
Jeremiah R Brown1, Clay A Block, David J Malenka
1The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire, USA. jbrown@Dartmouth.edu
Insights
Combination therapy with N-acetylcysteine (NAC) and sodium bicarbonate (NaHCO3) significantly reduces contrast-induced acute kidney injury (AKI). However, this combination did not significantly lower the incidence of dialysis-dependent renal failure.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Contrast-induced acute kidney injury (AKI) is a significant complication following cardiac catheterization and percutaneous coronary interventions (PCI).
- Prophylactic strategies for contrast-induced AKI remain an area of active research and clinical need.
- Existing evidence supports combination therapy, yet its widespread implementation is limited.
Discussion:
- This meta-analysis evaluated the efficacy of N-acetylcysteine (NAC) combined with sodium bicarbonate (NaHCO3) for preventing contrast-induced AKI.
- The study synthesized data from ten randomized controlled trials to assess the impact on AKI and renal failure requiring dialysis.
- The definition of contrast-induced AKI involved a significant increase in serum creatinine levels post-procedure.
Key Insights:
- Combination therapy with NAC and NaHCO3 demonstrated a 35% reduction in contrast-induced AKI.
- The prophylactic regimen did not yield a statistically significant decrease in the rate of renal failure necessitating dialysis.
- The findings highlight the effectiveness of this combination for preventing AKI but not end-stage renal failure.
Outlook:
- Combination prophylaxis with NAC and NaHCO3 should be integrated into the care of high-risk patients, including those with chronic kidney disease or undergoing emergent procedures.
- Strong consideration should be given to this prophylactic approach for all patients undergoing interventional radio-contrast procedures.
- Further research may explore optimal dosing and patient selection for maximizing benefits and minimizing risks.
Objectives:
We sought to conduct a meta-analysis to compare N-acetylcysteine (NAC) in combination with sodium bicarbonate (NaHCO(3)) for the prevention of contrast-induced acute kidney injury (AKI).
Background:
Contrast-induced AKI is a serious consequence of cardiac catheterizations and percutaneous coronary interventions (PCI). Despite recent supporting evidence for combination therapy, not enough has been done to prevent the occurrence of contrast-induced AKI prophylactically.
Methods:
Published randomized controlled trial data were collected from OVID/PubMed, Web of Science, and conference abstracts. The outcome of interest was contrast-induced AKI, defined as a >or=25% or >or=0.5 mg/dl increase in serum creatinine from baseline. Secondary outcome was renal failure requiring dialysis.
Results:
Ten randomized controlled trials met our criteria. Combination treatment of NAC with intravenous NaHCO(3) reduced contrast-induced AKI by 35% (relative risk: 0.65; 95% confidence interval: 0.40 to 1.05). However, the combination of N-acetylcysteine plus NaHCO(3) did not significantly reduce renal failure requiring dialysis (relative risk: 0.47; 95% confidence interval: 0.16 to 1.41).
Conclusions:
Combination prophylaxis with NAC and NaHCO(3) substantially reduced the occurrence of contrast-induced AKI overall but not dialysis-dependent renal failure. Combination prophylaxis should be incorporated for all high-risk patients (emergent cases or patients with chronic kidney disease) and should be strongly considered for all interventional radio-contrast procedures.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Prevention of Further Absorption of Poison
Pharmaceutical Poisoning: Treatment Strategies
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
